Delhi, India — November 2025 — Ken Research released its strategic industry report titled “The US Diabetic Devices Market Outlook to 2030 – Growth to be Led by Next-Generation Technology,” revealing that the current market is valued at USD 26.7 billion in 2025 . The comprehensive study outlines how the market has evolved from a niche healthcare segment into a mainstream lifestyle necessity—driven by the rising diabetic and ageing population, increasing adoption of home-based glucose monitoring, and technological innovations in continuous glucose monitoring (CGM) and smart insulin delivery systems. The report further highlights how AI-enabled sensors, wearable CGM devices, and hybrid closed-loop insulin pumps are redefining diabetes management in the U.S., enhancing patient convenience and supporting a long-term transition toward personalized and connected care solutions.
Key Market Insights
• Steady Market Expansion: The US Diabetic Devices Market grew consistently from 2007 to 2013, supported by the rising prevalence of diabetes and improving affordability of home-based glucose monitoring systems.
• Segment Dominance: The Self-Monitoring Blood Glucose (SMBG) devices segment held the largest market share in 2013, accounting for the majority of revenue despite a gradual decline in share since 2010.
• Innovation in CGM Systems: Continuous Glucose Monitoring (CGM) devices — introduced in 1999 — have recorded phenomenal growth between 2010 and 2013, positioning the US as a leading global revenue contributor in this category.
• Shift in Insulin Delivery Trends: The adoption of insulin pens and pumps is replacing traditional syringes, with insulin pumps’ share rising steadily from 2007 to 2013.
• Market Outlook: The overall industry is expected to continue growing at a healthy pace through 2030, led by new-generation technologies such as Artificial Pancreas Systems that integrate CGM and insulin delivery functionalities.

Market Segmentation Overview
• SMBG Devices: Includes glucose meters, test strips, and lancing devices — valued at USD ~ million in 2013, projected to reach USD ~ million by 2030.
• CGM Systems: Continuous real-time glucose monitoring, growing rapidly with key players like Medtronic and Dexcom leading innovation.
• Insulin Delivery Devices: Comprising insulin syringes, pens, and pumps — dominated by Medtronic, Novo Nordisk, and Sanofi.

Key Growth Drivers
1. Rising Diabetic Population: Increasing lifestyle diseases and an ageing demographic continue to expand the base of chronic diabetic patients in the US.
2. Technological Innovation: Next-generation devices, including implantable sensors and artificial pancreas systems, enhance real-time monitoring and dosage precision.
3. Home-Based Care Adoption: Higher convenience and affordability have fueled the adoption of portable monitoring devices across households.
4. Product Diversification by Key Players: Companies like Roche Diagnostics, LifeScan, and Abbott Diabetes Care are introducing integrated digital solutions for glucose management.

Executive Insight
“The evolution of diabetic care from conventional SMBG to continuous monitoring and automated insulin delivery marks a major transformation in preventive healthcare,” said a Senior Research Director at Ken Research. “The US market stands at the forefront of this shift, setting global benchmarks for innovation and accessibility.”

Future Outlook
The US Diabetic Devices Industry is projected to maintain robust growth momentum through 2030, supported by increasing device penetration, continuous R&D investments, and improved patient awareness. The integration of CGM and insulin delivery solutions is likely to redefine diabetes management efficiency and quality of life for patients across the country.

Key Players Overview
Roche Diagnostics – A global leader in in-vitro diagnostics, Roche continues to dominate the Self-Monitoring Blood Glucose (SMBG) segment in the US through its Accu-Chek product line. The company focuses on accuracy and patient convenience, integrating smart data-sharing technologies to enhance diabetic self-care.
LifeScan – A subsidiary of Johnson & Johnson, LifeScan is renowned for its OneTouch glucose monitoring systems. The brand holds a strong legacy in the SMBG category, emphasizing simplicity and reliability for daily glucose tracking among Type 1 and Type 2 diabetics.
Abbott Diabetes Care – Abbott is a major player driving innovation in continuous glucose monitoring with its FreeStyle Libre technology. The company’s sensor-based system offers real-time insights and has accelerated the shift from traditional test strips to wearable CGM devices.
Medtronic – As a pioneer in insulin delivery and CGM integration, Medtronic leads the market with advanced MiniMed insulin pumps and implantable glucose sensors. Its research on Artificial Pancreas systems positions it at the forefront of automated diabetes management solutions.
Dexcom – A key innovator in real-time Continuous Glucose Monitoring (CGM), Dexcom has disrupted the diabetic device landscape through devices like the Dexcom G6, focusing on continuous, calibration-free tracking and smartphone integration for enhanced patient engagement.
Novo Nordisk – A global pharmaceutical leader specializing in diabetes care, Novo Nordisk drives innovation in insulin formulations and delivery pens. Its pen-based solutions emphasize dose precision, user comfort, and accessibility, complementing its pharmaceutical insulin portfolio.
Sanofi – Sanofi combines its pharmaceutical expertise with medical device innovation through its insulin delivery systems. The company is actively expanding its smart insulin pens and connected care solutions to strengthen patient compliance and real-time dosage tracking.

About the Report
The 140+ page report offers a comprehensive analysis of the US Diabetic Devices Market, covering market size, segmentation (SMBG, CGM, and Insulin Delivery), key trends, regulatory framework, and competitive landscape. It provides market share data of major players and detailed forecasts till 2030.

To Know More, Access the Full Report:
🔗 The US Diabetic Devices Industry
https://www.kenresearch.com/industry-reports/us-diabetic-device-market?utm_source=Microblog&utm_medium=referral&utm_campaign=sameeksha
For Sample Report & Customized Consultation:
📩 Request Sample Here
https://www.kenresearch.com/sample-report/us-diabetic-device-marketutm_source=microblog&utm_medium=referral&utm_campaign=sameeksha

Related Reports
• US Medical Devices Market Outlook 2028
https://www.kenresearch.com/industry-reports/us-medical-device-market?utm_source=Microblog&utm_medium=referral&utm_campaign=sameeksha

• Indonesia Diabetes Care Devices Market Outlook 2030
https://www.kenresearch.com/industry-reports/indonesia-diabetes-care-devices-market-industry?utm_source=Microblog&utm_medium=referral&utm_campaign=sameeksha

• Egypt Healthcare Device And Medical Equipment Market
https://www.kenresearch.com/egypt-healthcare-devices-and-medical-equipment-market?utm_source=Microblog&utm_medium=referral&utm_campaign=sameeksha

About Ken Research:
Ken Research delivers strategic market intelligence that drives confident decision-making for industry leaders. With specialized expertise in high-growth markets across emerging economies, the firm provides data-driven insights that translate into competitive advantage for global organizations and investors